Immunological differences between primary and metastatic breast cancer von Szekely, B., Bossuyt, V., Li, X., Wali, V.B., Patwardhan, G.A., Frederick, C., Silber, A., Park, T., Harigopal, M., Pelekanou, V., Zhang, M., Yan, Q., Rimm, D.L., Bianchini, G., Hatzis, C., Pusztai, L.

Volltext

Quantitative systems pharmacology modeling sheds light into the dose response relationship of a trispecific T cell engager in multiple myeloma von Abrams, R. E., Pierre, K., El-Murr, N., Seung, E., Wu, L., Luna, E., Mehta, R., Li, J., Larabi, K., Ahmed, M., Pelekanou, V., Yang, Z.-Y., van de Velde, H., Stamatelos, S. K.

Volltext

Identification of Polyproline II Regions Derived From the Proline-Rich Nuclear Receptor Coactivators PNRC and PNRC2: New Insights for ERα Coactivator Interactions von Byrne, C., Miclet, E., Broutin, I., Gallo, D., Pelekanou, V., Kampa, M., Castanas, E., Leclercq, G., Jacquot, Y.

Volltext

Identification of Polyproline II Regions Derived From the Proline-Rich Nuclear Receptor Coactivators PNRC and PNRC2: New Insights for ER[alpha] Coactivator Interactions von Byrne, C, Miclet, E, Broutin, I, Gallo, D, Pelekanou, V, Kampa, M, Castanas, E, Leclercq, G, Jacquot, Y

Volltext

Abstract P2-09-06: Quantitative spatial profiling of tumor associated macrophages and the PD-1/PD-L1 interaction in breast cancer von Pelekanou, V, Neumeister, V, Pusztai, L, Rimm, DL

Volltext

532 TRANSCRIPTOME ANALYSIS OF QUERCETIN EFFECT IN HEPATOCELLULAR CANCER CELLS von Notas, G, Nifli, A.-P, Kampa, M, Pelekanou, V, Vercauteren, J, Castanas, E

Volltext

Abstract P4-03-04: Tumor infiltrating macrophages, lymphocytes and matrix metalloproteinase 9 (MMP-9) expression in breast cancer von Pelekanou, V, Brown, JR, Rimm, DL

Volltext

333TiP AMEERA-1: Phase I/II study of amcenestrant (SAR439859), an oral selective estrogen receptor (ER) degrader (SERD), with alpelisib in postmenopausal women with ER+/ human epid... von Campone, M., Bardia, A., Kabos, P., Chandarlapaty, S., Neven, P., Boni, V., Lord, S., Cartot-Cotton, S., Celanovic, M., Gosselin, A., Pelekanou, V., Linden, H.M.

Volltext

Recent insights into the effect of natural and environmental estrogens on mammary development and carcinogenesis von Pelekanou, Vassiliki, Leclercq, Guy

Volltext

1648P Deep learning identifies oncogenic genetic alterations in BRAF and NTRK in H&E whole slide images from thyroid carcinomas von Williams, M., Pelekanou, V., Hoehne, J., Zoete, J.D., Schmitz, A., Bal, T.A., Banerji, T., Ferrer, J., Bernard-Gauthier, V., Rudolph, M., Theron, M., Cabanillas, M.E., Lenga, M., Di Tomaso, E.

Volltext

264P AMEERA-1: Subgroup analyses of phase I/II study of amcenestrant (SAR439859), an oral selective estrogen receptor (ER) degrader (SERD), with palbociclib in postmenopausal women... von Chandarlapaty, S., Linden, H.M., Neven, P., Petrakova, K., Bardia, A., Kabos, P., Braga, S., Boni, V., Pelekanou, V., Ternès, N., Gosselin, A., Celanovic, M., Cohen, P., Paux, G., Campone, M.

Volltext

Membrane-initiated steroid action in breast and prostate cancer von Kampa, Marilena, Pelekanou, Vassiliki, Castanas, Elias

Volltext

277MO SAR439859, an oral selective estrogen receptor (ER) degrader (SERD), in ER+/ HER2- metastatic breast cancer (mBC): Biomarker analyses from a phase I/II study von Chandarlapaty, S., Bardia, A., Lord, S., Linden, H., Pelekanou, V., Ternes, N., Ming, J., Boutet, V., Boitier, E., Gosselin, A., Lee, J. Sang, Dos-Santos Bele, W., Protopopov, A., Celanovic, M., Bauchet, A-L., Campone, M.

Volltext

P8 Potentiation of erythropoietin (EPO) action by membrane steroid receptor agonists von Pelekanou, V, Kampa, M, Castanas, E

Volltext

Abstract PD6-02: Immunological differences between primary and metastatic breast cancer von Szekely, B, Bossuyt, V, Li, X, Baine, M, Silber, A, Sanft, T, Hofstatter, E, Mougalian, S, Baghwagar, S, Neumeister, V, Pelekanou, V, Hatzis, C, Pusztai, L

Volltext

Erythropoietin and steroid membrane initiated actions interact in breast cancer cells leading to enhanced cell survival von Kampa, M, Pelekanou, V, Vassou, D, Castanas, E

Volltext

Abstract P4-02-01: Analytical validation of an automated digital scoring protocol for Ki67: International multicenter collaboration study von Acs, B, Leung, SC, Pelekanou, V, Bai, Y, Martinez-Morilla, S, Toki, M, Chang, MC, Gholap, A, Jadhav, A, Hugh, JC, Bigras, G, Laurinavicius, A, Augulis, R, Levenson, R, Todd, A, Piper, T, Virk, S, van der Vegt, B, Hayes, DF, Dowsett, M, Nielsen, TO, Rimm, DL

Volltext

P40 Erythropoietin (EPO) and its receptors (EPOR) detection in human breast cancer specimens: correlation with steroid receptors (membrane intracellular) and other biological and c... von Pelekanou, V, Kampa, M, Kafousi, M, Dambaki, K, Darivianaki, K, Vrekousis, T, Sanidas, E, Tsiftsis, D, Stathopoulos, E, Castanas, E

Volltext

Regulation of TNF-superfamily members by erythropoietin, in breast cancer von Pelekanou, V, Kampa, M, Darivianaki, K, Stathopoulos, E.N, Tsapis, A, Castanas, E

Volltext

Analytical validation of an automated digital scoring protocol for Ki67: International multicenter collaboration study von Acs, B, Leung, SC, Pelekanou, V, Bai, Y, Martinez-Morilla, S, Toki, M, Chang, MC, Gholap, A, Jadhav, A, Hugh, JC, Bigras, G, Laurinavicius, A, Augulis, R, Levenson, R, Todd, A, Piper, T, Virk, S, van der Vegt, B, Hayes, DF, Dowsett, M, Nielsen, TO, Rimm, DL

Volltext